TABLE 6.
Relevant biosafety and biosecurity documents applicable for gene editing technologies adapted from the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), US.
Guidance titles | Year published |
World Health Organization (WHO)a | |
Guidance on regulations for the transport of infectious substances 2019–2020 | 2019 |
Biosafety video series | 2019 |
WHO Global Consultative Meeting on the Safe Shipment of Infectious Substances: 15–16 March 2018 | 2018 |
WHO consultative meeting high/maximum containment (biosafety level 4) laboratories networking: 13-15 December 2017 | 2018 |
Report of an extended meeting of the biosafety advisory group: 13–15 December 2016 | 2018 |
Extended Biosafety Advisory Group meeting, 24–26 November 2014 | 2015 |
Laboratory Biorisk Management: Strategic Framework for Action 2012–2016 | 2012 |
Responsible life sciences research for global health security | 2010 |
Biorisk management: Laboratory biosecurity guidance | 2006 |
Public health response to biological and chemical weapons: WHO guidance | 2004 |
Laboratory biosafety manual: 3rd Edition | 2004 |
Centers for Disease Control and Prevention (CDC), USb | |
Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition | 2009 |
aAdapted from WHO Biorisk management: core documents: https://www.who.int/ihr/publications/bioriskmanagement_1/en/.
bAdapted from CDC Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition: https://www.cdc.gov/labs/BMBL.html.